Aclaris Therapeutics
MO - St. LouisBiotechnology
Focus: Aclaris Therapeutics is a St. Louis-based biotech focused on novel topical dermatological therapies with one FDA-approved product (ESKATA) and a robust clinical pipeline spanning dermatology, rheumatology, and oncology.
Profile data last refreshed 20h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Aclaris Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Aclaris Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Peak9.2yr
FDA-approved topical therapy representing core commercial asset with 13-year LOE runway; mechanism of action remains undetermined despite clinical efficacy.
Help build intelligence for Aclaris Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.